vs
Side-by-side financial comparison of DMC Global Inc. (BOOM) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $143.5M, roughly 1.2× DMC Global Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.8%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -7.3%).
DMC Mining Services is a mining services contractor founded in 1980 operating in Canada, the United States, Chile, and Mongolia
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
BOOM vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.5M | $168.4M |
| Net Profit | $-11.2M | — |
| Gross Margin | 17.1% | — |
| Operating Margin | -7.8% | 50.6% |
| Net Margin | -7.8% | — |
| Revenue YoY | -5.8% | 143.7% |
| Net Profit YoY | -3871.6% | — |
| EPS (diluted) | $-0.60 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $143.5M | $168.4M | ||
| Q3 25 | $151.5M | $87.3M | ||
| Q2 25 | $155.5M | $82.4M | ||
| Q1 25 | $159.3M | $65.0M | ||
| Q4 24 | $152.4M | $69.1M | ||
| Q3 24 | $152.4M | $51.6M | ||
| Q2 24 | $171.2M | $73.8M | ||
| Q1 24 | $166.9M | $137.7M |
| Q4 25 | $-11.2M | — | ||
| Q3 25 | $-3.1M | $-31.3M | ||
| Q2 25 | $116.0K | $-12.7M | ||
| Q1 25 | $677.0K | $-40.5M | ||
| Q4 24 | $296.0K | — | ||
| Q3 24 | $-101.3M | $-29.5M | ||
| Q2 24 | $4.0M | $-61.9M | ||
| Q1 24 | $2.6M | $61.0M |
| Q4 25 | 17.1% | — | ||
| Q3 25 | 21.7% | — | ||
| Q2 25 | 23.6% | — | ||
| Q1 25 | 25.9% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 25.4% | — |
| Q4 25 | -7.8% | 50.6% | ||
| Q3 25 | 0.4% | -11.4% | ||
| Q2 25 | 2.5% | 8.6% | ||
| Q1 25 | 4.1% | -34.0% | ||
| Q4 24 | -0.5% | -6.4% | ||
| Q3 24 | -97.7% | -31.0% | ||
| Q2 24 | 6.8% | 3.5% | ||
| Q1 24 | 4.0% | 52.5% |
| Q4 25 | -7.8% | — | ||
| Q3 25 | -2.0% | -35.9% | ||
| Q2 25 | 0.1% | -15.4% | ||
| Q1 25 | 0.4% | -62.2% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | -66.5% | -57.2% | ||
| Q2 24 | 2.3% | -83.9% | ||
| Q1 24 | 1.5% | 44.3% |
| Q4 25 | $-0.60 | $0.32 | ||
| Q3 25 | $-0.10 | $-0.16 | ||
| Q2 25 | $-0.24 | $-0.06 | ||
| Q1 25 | $0.04 | $-0.21 | ||
| Q4 24 | $-0.18 | $-0.14 | ||
| Q3 24 | $-8.27 | $-0.15 | ||
| Q2 24 | $0.24 | $-0.33 | ||
| Q1 24 | $0.01 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $167.9M |
| Total DebtLower is stronger | $50.6M | — |
| Stockholders' EquityBook value | $242.1M | $-302.0M |
| Total Assets | $635.8M | $465.9M |
| Debt / EquityLower = less leverage | 0.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.9M | $167.9M | ||
| Q3 25 | $26.4M | $92.4M | ||
| Q2 25 | $12.4M | $86.1M | ||
| Q1 25 | $14.7M | $114.6M | ||
| Q4 24 | $14.3M | $144.8M | ||
| Q3 24 | $14.5M | $144.7M | ||
| Q2 24 | $14.6M | $189.3M | ||
| Q1 24 | $20.4M | $226.6M |
| Q4 25 | $50.6M | — | ||
| Q3 25 | $56.5M | — | ||
| Q2 25 | $58.7M | — | ||
| Q1 25 | $72.4M | — | ||
| Q4 24 | $70.8M | — | ||
| Q3 24 | $74.2M | — | ||
| Q2 24 | $84.1M | — | ||
| Q1 24 | $88.0M | — |
| Q4 25 | $242.1M | $-302.0M | ||
| Q3 25 | $253.0M | $-451.4M | ||
| Q2 25 | $253.9M | $-433.5M | ||
| Q1 25 | $253.9M | $-426.2M | ||
| Q4 24 | $251.0M | $-388.7M | ||
| Q3 24 | $256.5M | $-370.2M | ||
| Q2 24 | $416.0M | $-344.2M | ||
| Q1 24 | $409.9M | $-294.3M |
| Q4 25 | $635.8M | $465.9M | ||
| Q3 25 | $644.1M | $364.0M | ||
| Q2 25 | $645.0M | $347.1M | ||
| Q1 25 | $670.6M | $324.0M | ||
| Q4 24 | $671.3M | $343.8M | ||
| Q3 24 | $702.0M | $314.1M | ||
| Q2 24 | $869.5M | $352.3M | ||
| Q1 24 | $860.0M | $373.1M |
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.2M | $45.2M |
| Free Cash FlowOCF − Capex | $9.6M | — |
| FCF MarginFCF / Revenue | 6.7% | — |
| Capex IntensityCapex / Revenue | 3.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $37.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.2M | $45.2M | ||
| Q3 25 | $18.6M | $-4.3M | ||
| Q2 25 | $15.2M | $-31.4M | ||
| Q1 25 | $4.5M | $-22.6M | ||
| Q4 24 | $11.8M | $-35.0M | ||
| Q3 24 | $19.0M | $-35.3M | ||
| Q2 24 | $2.3M | $-7.2M | ||
| Q1 24 | $13.4M | $53.8M |
| Q4 25 | $9.6M | — | ||
| Q3 25 | $14.4M | — | ||
| Q2 25 | $12.3M | — | ||
| Q1 25 | $709.0K | — | ||
| Q4 24 | $6.1M | — | ||
| Q3 24 | $12.9M | $-35.5M | ||
| Q2 24 | $-204.0K | $-7.3M | ||
| Q1 24 | $10.5M | $53.8M |
| Q4 25 | 6.7% | — | ||
| Q3 25 | 9.5% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 8.5% | -68.7% | ||
| Q2 24 | -0.1% | -9.9% | ||
| Q1 24 | 6.3% | 39.0% |
| Q4 25 | 3.9% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 1.9% | 0.0% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | 3.7% | 0.0% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 1.5% | 0.1% | ||
| Q1 24 | 1.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 131.43× | — | ||
| Q1 25 | 6.63× | — | ||
| Q4 24 | 39.90× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 5.24× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BOOM
| Dyna Energetics Segment | $68.9M | 48% |
| Other | $57.0M | 40% |
| Nobel Clad Segment | $17.7M | 12% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
